Mephentermine
A sympathomimetic agent used as a cardiac stimulant and vasopressor
Mephentermine is a sympathomimetic agent primarily used as a cardiac stimulant and vasopressor. It is known for its ability to increase blood pressure by stimulating the release of norepinephrine from adrenergic nerve endings. Mephentermine is often used in the management of hypotension during anesthesia and surgical procedures.
Pharmacology[edit]
Mephentermine acts as an indirect sympathomimetic by promoting the release of norepinephrine, which in turn stimulates alpha-adrenergic receptors leading to vasoconstriction and increased blood pressure. It also has some direct action on beta-adrenergic receptors, which can increase cardiac output.
Medical Uses[edit]
Mephentermine is primarily used to treat hypotension that occurs during anesthesia. It is administered intravenously or intramuscularly to rapidly increase blood pressure. The drug is also used in some cases to treat orthostatic hypotension.
Side Effects[edit]
Common side effects of mephentermine include tachycardia, palpitations, headache, and nausea. In some cases, it can cause anxiety and tremors. Due to its sympathomimetic effects, it may also lead to hypertension if not properly monitored.
Synthesis[edit]

The synthesis of mephentermine involves the reaction of phenylacetone with methylamine in the presence of a reducing agent. This process results in the formation of the secondary amine structure characteristic of mephentermine.
Chemical Structure[edit]

Mephentermine is a phenethylamine derivative with a chemical structure similar to that of amphetamine. It contains a phenyl ring bonded to an ethylamine chain, with a methyl group attached to the nitrogen atom.
Related Compounds[edit]
Mephentermine is related to other phenethylamines and amphetamine derivatives. It shares structural similarities with methamphetamine and amphetamine, but its pharmacological effects are distinct due to its specific action on adrenergic receptors.
Regulation and Legal Status[edit]
The legal status of mephentermine varies by country. In some regions, it is classified as a controlled substance due to its potential for abuse and its stimulant properties. It is important for healthcare providers to be aware of the regulations governing its use in their respective jurisdictions.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian